Literature DB >> 12138051

The impact of corticosteroids on growth and bone health.

T Mushtaq1, S F Ahmed.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12138051      PMCID： PMC1719206          DOI： 10.1136/adc.87.2.93

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  59 in total

1.  Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects.

Authors:  M Sakakura; K Takebe; S Nakagawa
Journal:  J Clin Endocrinol Metab       Date:  1975-05       Impact factor: 5.958

2.  Inflammatory bowel disease and predisposition to osteopenia.

Authors:  F J Cowan; J T Warner; F D Dunstan; W D Evans; J W Gregory; H R Jenkins
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

3.  Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.

Authors:  S C Kaste; D Jones-Wallace; S R Rose; J M Boyett; R H Lustig; G K Rivera; C H Pui; M M Hudson
Journal:  Leukemia       Date:  2001-05       Impact factor: 11.528

4.  Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate-day prednisone therapy.

Authors:  C Polito; A La Manna; M R Papale; G Villani
Journal:  Clin Pediatr (Phila)       Date:  1999-05       Impact factor: 1.168

5.  Reduced bone density at completion of chemotherapy for a malignancy.

Authors:  P Arikoski; J Komulainen; P Riikonen; J S Jurvelin; R Voutilainen; H Kröger
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

6.  Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.

Authors:  A M Boot; J Bouquet; E P Krenning; S M de Muinck Keizer-Schrama
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

7.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.

Authors:  P M Crofton; S F Ahmed; J C Wade; R Stephen; M W Elmlinger; M B Ranke; C J Kelnar; W H Wallace
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

9.  Osteopenia in Crohn's disease.

Authors:  F J Cowan; D R Parker; H R Jenkins
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

10.  Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women.

Authors:  R Crilly; M Cawood; D H Marshall; B E Nordin
Journal:  J R Soc Med       Date:  1978-10       Impact factor: 18.000
View more
  27 in total

1.  Chronic non-granulomatous supraglottitis of a male adolescent and its successful management with azathioprine.

Authors:  Aaron Kovacs; Shankar Haran; Paul Paddle
Journal:  BMJ Case Rep       Date:  2019-04-03

2.  Growth Pattern in Children with Systemic Lupus Erythematosus.

Authors:  Eiman Abdalla; Lakshamanan Jeyaseelan; Irfan Ullah; Reem Abdwani
Journal:  Oman Med J       Date:  2017-07

3.  Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.

Authors:  Surabhi Choudhary; Indira Agarwal; Mandalam S Seshadri
Journal:  Pediatr Nephrol       Date:  2014-01-12       Impact factor: 3.714

4.  Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose.

Authors:  Piotr Dobrowolski; Ewa Tomaszewska; Siemowit Muszyński; Tomasz Blicharski; Stefan G Pierzynowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 5.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia.

Authors:  F K Grote; L W A Van Suijlekom-Smit; D Mul; W C J Hop; R Ten Cate; W Oostdijk; W Van Luijk; C J A Jansen-van Wijngaarden; S M P F De Muinck Keizer-Schrama
Journal:  Arch Dis Child       Date:  2005-10-13       Impact factor: 3.791

7.  Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.

Authors:  Diana Ribeiro; Sophie Zawadynski; Laure F Pittet; Thierry Chevalley; Eric Girardin; Paloma Parvex
Journal:  Eur J Pediatr       Date:  2015-01-10       Impact factor: 3.183

8.  Growth Hormone Receptor Gene Expression Increase Reflects Nutritional Status Improvement in Patients Affected by Crohn's Disease.

Authors:  Sara Pagani; Elena Bozzola; Caterina Strisciuglio; Cristina Meazza; Erasmo Miele; M Malamisura; Paola De Angelis; Mauro Bozzola
Journal:  Front Pediatr       Date:  2018-11-12       Impact factor: 3.418

Review 9.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

Review 10.  Late consequences of chronic pediatric illness.

Authors:  Susan Turkel; Maryland Pao
Journal:  Psychiatr Clin North Am       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.